SCHEMBL6033901

SCHEMBL6033901

Cc1ccc(C(=O)Nc2ccc(-n3ccnc3)cc2)c(Nc2ncccc2-c2ccncn2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 9/20 0.55
KDR P35968 8/20 0.55
LCK P06239 2/20 0.47
BRAF P15056 2/20 0.47
MAPK14 Q16539 1/20 0.47
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
CYP3A4 P08684 1/20 0.44
CD38 P28907 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
F10 P00742 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
PTK2 Q05397 1/20 0.39
GAA P10253 1/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1264155 0.86 TEK (0.76) TEKKDRLCKBRAFMAPK14
SCHEMBL6032952 0.85 TEK (0.57) TEKKDRLCKBRAFMAPK14
SCHEMBL1265457 0.74 TEK (0.73) TEKKDRLCKBRAFMAPK14
SCHEMBL2296129 0.73 TEK (0.75) TEKKDRLCKBRAFMAPK14
SCHEMBL1263743 0.72 TEK (0.91) TEKKDRLCKBRAFMAPK14
SCHEMBL1264070 0.72 TEK (0.75) TEKKDRLCKBRAFMAPK14
SCHEMBL1264700 0.71 TEK (0.86) TEKKDRLCKBRAFMAPK14
SCHEMBL1264246 0.71 TEK (0.86) TEKKDRLCKBRAFMAPK14
SCHEMBL5262340 0.71 TEK (0.67) TEKKDRLCKBRAFMAPK14
SCHEMBL1264888 0.71 TEK (1.00) TEKKDRLCKBRAFMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060009453-A1 Protein kinase modulators and method of use AMGEN INC. 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060009453-A1 Protein kinase modulators and method of use PHKG1, PRKCH, BMP2K TEK 215/4885KDR 58/4885LCK 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.